Literature DB >> 20189165

Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence.

Nimish Sidhpura1, Friedbert Weiss, Rémi Martin-Fardon.   

Abstract

BACKGROUND: Growing evidence supports a role of metabotropic glutamate receptors (mGluRs) in ethanol reinforcement, ethanol seeking, and ethanol withdrawal. To extend the understanding of the role of mGluRs in the addiction-relevant effects of ethanol as well as of the treatment target potential of these receptors for alcohol abuse, the effects of a selective mGlu2/3 agonist (LY379268) and a selective mGlu5 antagonist (MTEP) were tested on two processes central to alcohol addiction: ethanol reinforcement and stress-induced reinstatement of ethanol seeking in rats with a history of ethanol dependence.
METHODS: Following operant ethanol self-administration training, male Wistar rats were made dependent by intragastric ethanol intubations. Ethanol dependence was confirmed by the presence of somatic withdrawal signs. Following 2 weeks of withdrawal, stable ethanol self-administration was reestablished, and the effects of LY379268 (0-3 mg/kg subcutaneous) and MTEP (0-3 mg/kg, intraperitoneal) on ethanol self-administration were determined in both nondependent and postdependent rats. A second set of rats underwent extinction training and then was tested for the effects of LY379268 or MTEP on reinstatement of ethanol seeking induced by footshock stress.
RESULTS: LY379268 and MTEP dose-dependently reduced both ethanol self-administration and reinstatement of ethanol seeking induced by footshock stress. Additionally, LY379268 was more effective than MTEP in inhibiting both behaviors in postdependent than in nondependent animals.
CONCLUSIONS: These findings suggest that neuroadaptation associated with chronic ethanol exposure or withdrawal alters the sensitivity of mGlu2/3 receptors, with implications for the understanding of the neural basis of alcohol dependence and the treatment target potential of these receptors. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189165      PMCID: PMC2854322          DOI: 10.1016/j.biopsych.2010.01.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  71 in total

1.  Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.

Authors:  Matthias E Liechti; Athina Markou
Journal:  Eur J Pharmacol       Date:  2006-10-17       Impact factor: 4.432

Review 2.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

3.  Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving.

Authors:  Lin Lu; Jamie L Uejima; Sarah M Gray; Jennifer M Bossert; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

4.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

5.  Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.

Authors:  J Cartmell; J A Monn; D D Schoepp
Journal:  Psychopharmacology (Berl)       Date:  2000-03       Impact factor: 4.530

6.  Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats.

Authors:  R Martin-Fardon; R Ciccocioppo; M Massi; F Weiss
Journal:  Neuroreport       Date:  2000-06-26       Impact factor: 1.837

7.  Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism.

Authors:  Michael S Cowen; Elena Krstew; Andrew J Lawrence
Journal:  Psychopharmacology (Berl)       Date:  2006-11-10       Impact factor: 4.530

8.  Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.

Authors:  Matthias E Liechti; Loic Lhuillier; Klemens Kaupmann; Athina Markou
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

9.  Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats.

Authors:  Joyce Besheer; Sara Faccidomo; Julie J M Grondin; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

Review 10.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more
  59 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

Review 3.  Neurochemical and neurostructural plasticity in alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2012-04-16       Impact factor: 4.418

4.  The Toll-Like Receptor 3 Agonist Poly(I:C) Induces Rapid and Lasting Changes in Gene Expression Related to Glutamatergic Function and Increases Ethanol Self-Administration in Rats.

Authors:  Patrick A Randall; Ryan P Vetreno; Viren H Makhijani; Fulton T Crews; Joyce Besheer
Journal:  Alcohol Clin Exp Res       Date:  2018-12-16       Impact factor: 3.455

5.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

6.  Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence.

Authors:  Peter R Kufahl; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

Review 7.  An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism.

Authors:  H C Becker; M F Lopez
Journal:  Int Rev Neurobiol       Date:  2016-03-10       Impact factor: 3.230

8.  Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala.

Authors:  Reginald Cannady; Julie J M Grondin; Kristen R Fisher; Clyde W Hodge; Joyce Besheer
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

Review 9.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

10.  Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.

Authors:  Peter R Kufahl; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.